Parkinson's Disease Research

Parkinson's disease (PD) is a degenerative disease of the central nervous system that often impairs motor skills, speech, and other functions. Symptoms of the disease include resting tremor, bradykinesia and rigidity. The primary symptoms are the result of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Symptoms of the disease appear once 50-80% of dopamine neurons have died. Parkinson's disease is both chronic and progressive.

Parkinson's Disease Research Products Targets

Products for Parkinson's Disease Research - Page 60

  1. Cat.No. Product Name Information/Activity
  2. BCC6120 Conantokin G 93438-65-4 Conantokin G chemical structure
  3. BCC5980 Conantokin-R 202925-60-8 Conantokin-R chemical structure
  4. BCC5977 Conantokin-T 127476-26-0 Conantokin-T chemical structure
  5. BCC6581 (R)-CPP 126453-07-4 (R)-CPP chemical structure
  6. BCC6561 (RS)-CPP 100828-16-8 (RS)-CPP chemical structure
  7. BCC6999 D-CPP-ene 117414-74-1 D-CPP-ene chemical structure
  8. BCC6592 5,7-Dichlorokynurenic acid 131123-76-7 5,7-Dichlorokynurenic acid chemical structure
  9. BCC7758 5,7-Dichlorokynurenic acid sodium salt 1184986-70-6 5,7-Dichlorokynurenic acid sodium salt chemical structure
  10. BCC6619 (±)-1-(1,2-Diphenylethyl)piperidine maleate 207461-99-2 (±)-1-(1,2-Diphenylethyl)piperidine maleate chemical structure
  11. BCC6205 DQP 1105 380560-89-4 DQP 1105 chemical structure

Items 591 to 600 of 752 total